Navigation Links
Neuftec Responds to a Fundamental Inaccuracy in Oxonica PLC's Regulatory Announcement
Date:6/19/2008

dings to seek an injunction against Oxonica as well as damages in relation to product already sold and delivery up or destruction of all articles that would infringe Neuftec's European patent.

About Neuftec

Neuftec is a research & development company that owns patents in the fuel catalyst technology sector used in the production of the first version of EnviroxTM (2001-2007) that was manufactured by Advanced Nanotechnology ("ANO") of Australia under a manufacturing licence granted by Oxonica with authorization from Neuftec.

On 29 February 2008, IP Australia issued a re-examination report in respect of Neuftec's Australian patent. The patent had been issued in 2006 with 10 claims. In the re-examination report, IP Australia confirmed the patentability of the 10 claims as originally granted in 2006 in re-examination proceedings initiated by Oxonica.


'/>"/>
SOURCE Neuftec Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Neuftec Issues Patent Infringement Proceedings in the UK Against Oxonica
2. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
3. Updated Drug Development Scrip Report Responds to the Pharma Industrys Major Changes
4. Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
5. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
6. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
7. Bio-Identical Hormone Menopause Doctor Responds to Outrageous FDA News
8. Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol
9. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
10. MichBio Responds to Governors Plan to Repeal Tort Reform Laws
11. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Y,Calif.,Nov.24/PRNewswire-FirstCall/--GenomicHeal...,GenomicHealth,sExecutiveChairman,willpresentatthe...kCityonTuesday,December1,2009at10:00a.m.ET. ,, ...presentation,visittheInvestorRelationssectionofGen...h.com .Pleaseconnecttothewebsiteatleast15minutespr...
(Date:11/23/2009)... Nov. 23, 2009 In a provocative new study, a Univ... dioxide emissions the major cause of global warm...my collapses or society builds the equivalent of o...s unlikely that there will be any substantial near...n in carbon dioxide emission rates," says the new ...
(Date:11/23/2009)...A,ON,Nov.23/PRNewswire-FirstCall/-YMBioSciencesInc...opmentcompanythatidentifiesandadvancesadiverseport...gesofdevelopment,todayreportedthatCytopia(ASX:CYT)...YT387,apotent,orally-administeredJAK1/JAK2inhibito...Minnesota.AproposaltomergeCytopiaintoYMhasbeenprev...
(Date:11/23/2009)...EW,Calif.,Nov.23/PRNewswire/--Frost&Sullivan,t...iesfordemonstratingleadershipandinnovationThursday...ionAwardsBanquetheldinSanAntonio,Texas. ,, (Log...LOGO ) ,, TheHealthcareInnovationAwardsaregiven...hedeliveryandmanagementofhealthcare.Suchcompaniesh...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3
...n,(Nasdaq: CRGN ), a clinical-stage biopharmaceut...that Ronit Simantov, M.D., has joined CuraGen as,V...v is a seasoned and accomplished clinical oncologi... and academic positions. In her,previous position ...played,a key role in the successful clinical devel...
...or reducing risk of cancer ...l Therapeutics,Inc. (CTI) (Nasdaq: CTIC ; MTAX) h...eeting) on Tuesday, September 25, 2007 in Milan. T...ince a majority of CTI,s shares are,held by Italia...olders,re-elected Mary O. Mundinger, Dr. PH, and J...
...isfaction when theoretical work is eventually supp...eek for a team of Italian and US scientists when t...-old theory from a fluid science experiment that i...cecraft. , Although the Foton was only launched a... about the data they have received from their expe...
Other Biology Technology:CuraGen Appoints Clinical Oncologist as VP of Medical Development 2CuraGen Appoints Clinical Oncologist as VP of Medical Development 3CuraGen Appoints Clinical Oncologist as VP of Medical Development 4Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results 2Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results 3Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results 4Fluid theory confirmed by Foton 2
(Date:11/23/2009)...University of New Hampshire microbiologist Louis T...dvance understanding of the actinorhizal plants, w...trient-poor and contaminated soils. , The Unite...Tisa, a professor of molecular, cellular and biome...relationship between the bacteria Frankia and Casu...
(Date:11/23/2009)..., , , , , , , ,... AUDIO: , Dr Andrew Marshall, from the Env...cusses the discovery of Kinyongia magomberae and...Click here for more information. , , ,... , , , , , , , , A new ...
(Date:11/23/2009)...o Casabona is Director of the Interuniversity Prof...niversity and the University of the Basque Country...but also has other experts such as researchers in ... specialists in ethics. , The Interuniversity Pr...iversities of Deusto and the Basque Country was cr...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Research and legislation should go hand in hand, as much as possible 2For Many 9 11 Linked Trauma Emerged Years Later 53661 1For Many 9 11 Linked Trauma Emerged Years Later 53661 2For Many 9 11 Linked Trauma Emerged Years Later 53661 3Pilot study 3A Workplace yoga and meditation can lower feelings of stress 53656 1Pilot study 3A Workplace yoga and meditation can lower feelings of stress 53656 2Pilot study 3A Workplace yoga and meditation can lower feelings of stress 53656 3Pilot study 3A Workplace yoga and meditation can lower feelings of stress 53656 4CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine 53653 1CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine 53653 2CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine 53653 3CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine 53653 4
...on with fossils led to Natural Sciences and Engine...ering the oldest known dinosaur embryos and the ol...w, he is being honoured for more than 35 years of ...erican Association for the Advancement of Science ...ring its annual conference, being held from Feb. 1...
...ng 12 surgeons and 21 surgical residents, video ga...skill as assessed during a simulated surgery skill...sue of Archives of Surgery, one of the JAMA/Archiv...Israel Medical Center, New York, and colleagues as...sicians) about their video game–playing habits, th...
...ated that lead poisoning may have played a role in...ve been caused by the concentration of grape juice...ad-free gasoline has reduced damage to the environ...ncrease worldwide because lead is still used in ba..., there has thus far been little research into wha...
Other Biology News:Old dinosaur research leads to new honor 2Lead with a poisonous electron shield 2
Mouse Anti-Human HLA II DG+DR+DP Monoclonal Antibody, Unconjugated, Clone IQU9 from Diaclone
Duck Anti-Phenytoin-BSA Antibody, Unconjugated from Good Biotech Corp
Anti-Tropomyosin 4 Antibody, Unconjugated from CHEMICON
Mouse Anti-Cytokeratin 8 + 18 + 19 Monoclonal Antibody, Unconjugated, Clone 2A4 from Abcam
Biology Products: